CNO-PA — CNO Financial Group, Inc. 5.125

CNO Financial Group, Inc. Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Operating Earnings: Increased 33% to $1.05 per diluted share; up 42% excluding significant items.
• Sales Growth: Achieved fifteenth consecutive quarter of sales growth; total new annualized premiums rose 11%.
• Agent Count: Thirteenth consecutive quarter of producing agent count growth, up 3%.
• Book Value: Book value per diluted share (excluding AOCI) increased 5% to $38.98.
• Expense Ratio: Reported at 18.9%, lower than planned, expected to normalize throughout the year.
• Return on Equity: Trailing twelve-month operating ROE at 13.1%, 12.2% excluding significant items.

2. Strategic Updates and Business Highlights:

• Consumer Division: Strong performance with Life and Health NAP up 9%, total Health NAP up 20%, and Medicare policies sold up 24%.
• Worksite Division: Life and Health NAP increased 22%, with life insurance sales up 56% and hospital indemnity insurance up 121%.
• Technology Investments: Focus on AI and technology to enhance agent productivity and customer experience, including improvements in the Colonial Penn call center.
• Capital Management: Returned $77 million to shareholders through share repurchases; maintained a robust capital position with a risk-based capital ratio within target range.

3. Forward Guidance and Outlook:

• 2026 Guidance: Affirmed original guidance due to macroeconomic volatility; plans to refine projections later in the year.
• ROE Target: Indicated potential increase in 2027 ROE ambitions, emphasizing that the current 12% is a waypoint, not a destination.
• Market Conditions: Anticipated continued demand for Medicare Supplement products despite recent claims experience; rate increases expected to improve margins.

4. Challenges and Points of Concern:

• Medicare Supplement Claims: Experienced modestly adverse claims experience, necessitating rate increases to maintain profitability.
• Annuity Sales: Collected premiums down 2% due to strong prior year comparables; potential difficulty in sustaining growth in this segment.
• Expense Management: While current expenses were favorable, normalization is expected, which could impact future ratios.
• Market Volatility: Concerns regarding credit markets and investment opportunities, with a cautious approach to new investments.

5. Notable Q&A Insights:

• Medicare Supplement Pricing: Rate increases filed for both closed and open blocks, with expected approvals to improve benefit ratios by Q4 2026.
• Consumer Segment Performance: Management remains optimistic about long-term demand for life and annuity products despite short-term fluctuations.
• Investment Strategy: Focus on maintaining a disciplined investment posture amid market volatility, with a preference for quality and risk management.
• Long-term Care Performance: Favorable claims experience noted, with expectations for continued stability and positive margins.

Overall, CNO Financial Group demonstrated strong financial performance in Q1 2026, with significant growth across divisions and a commitment to strategic investments. However, challenges in claims experience and market volatility present potential headwinds that management is actively addressing.